Skip to main content

MATE Course

Starting June 2023, the Drug Enforcement Administration (DEA) enacted a new one-time training requirement for all DEA registered practitioners. 

All DEA-registered practitioners, except for practitioners that are solely veterinarians are required to take eight hours of training on the treatment and management of patients with opioid or other substance use disorders.

To help you meet this requirement, the office of Interprofessional Continuing Education presents the following courses.

 

Safe Opioid Prescribing Practices

  • Determine whether to initiate opioids for pain.
  • Select opioids and determine opioid dosages.
  • Decide duration of initial opioid prescription and conducting follow-up.
  • Assess risk and address potential harms of opioid use.

Faculty: Donna Rasmussen, PA-C Jennifer Olesen, APRN-FPA Rise Hatten, MD Jenia Heavens, MSN, APRN, FNP-C

Credits offered:

AMA PRA Category 1 Credit(s)™-3.00

CNE - 3.00

CPE - 3.00

Click here to View Safe Opioid Prescribing Practices

 

Intro to MOUD for Primary Care Providers

  • Address typical concerns about offering OUD treatment
  • Explain OUD as a chronic illness.
  • Screen and identify OUD in their patients
  • Describe what’s involved in integrating OUD treatment in their practice
  • Increase comfortablity in prescribing buprenorphine for OUD

Faculty: Donna Rasmussen, PA-C Sarah Messmer, MD Jennifer Olesen, APRN-FPA Amanda Vogel, FNP-C Pete Yunyongying,MD

Credit offered:

AMA PRA Category 1 Credit(s)™-1.5

CNE – 1.5

CPE – 1.5

Click here to view Intro to MOUD for Primary Care Providers

 

Buprenorphine Inductions for Primary Care Providers

  • Translate competence in best practices for low-dose induction of Buprenorphine
  • Identify needs for high dose induction opportunities/maintenance of Buprenorphine in the Fentanyl era
  • Discuss cases of induction/cross titration of Buprenorphine for persons using Methadone, Kratom, and other synthetic opioids
  • Describe the role of short-term opioid prescribing for patients inducing Buprenorphine

Faculty: Aimee Techau, MSN, PMHNP-BC, CARN-AP, NE-BC, PhDc

Credits offered:

AMA PRA Category 1 Credit(s)™-1.50

CNE – 1.50

CPE – 1.50

 

This course is coming soon!

 

 

Wound Care & Xylazine for Primary Care Providers

  • Address typical concerns about offering OUD treatment
  • Explain OUD as a chronic illness
  • Screen and identify OUD in their patients
  • Describe what’s involved in integrating OUD treatment in their practice
  • Increase confidence in prescribing buprenorphine for OUD

Faculty: Michael Huyck, DNP, APRN, FNP-BC

Credits offered:

AMA PRA Category 1 Credit(s)™-1.50

CNE – 1.50

CPE – 1.50

 

Click Here to view Wound Care and Xylazine for Primary Care Providers

 

Benzodiazepine & Stimulant Use

Faculty: Gail Basch, MD

This course is coming soon!

 

Stimulant Use

Faculty: Gail Basch, MD

This course is coming soon!

 

Working in an Interdisciplinary Team & Contingency Management

Faculty:Donna Rasmussen, PA-C

This course is coming soon!

 

IL Helpline MAR Toolkits Review Duration

  • Review procedures for treating patients with OUD in the Emergency Dept (ED).
  • Review procedures for treating patients with OUD in the Primary Care (PC) setting.
  • Review procedures for treating patients with OUD in the Perioperative context.
  • Review procedures for treating patients with OUD in the Perinatal context.

 

Credits offered:

AMA PRA Category 1 Credit(s)™-1.50

CNE – 1.50

CPE – 1.50

 

This course is coming soon!

 

Emergency Department MOUD and Harm Reduction Course

  • Recognize the potential traumas that ED providers may have experienced while treating patients with OUD.
  • Explain how these traumas can lead to stigmatizing practices that interfere with an ED provider’s ability to effectively treat patients with OUD.
  • Identify how the use of MOUD and harm reduction principles can empower ED providers to not only treat patients with greater confidence but also reduce stigma and improve outcomes.

Faculty: Konadu Fokuo, PhD Tanya Sorrell, PhD, PMHNP-BC

Credits offered:

AMA PRA Category 1 Credit(s)™-1.50

CNE – 1.50

CPE – 1.50

Click here to view Emergency Department MOUD and Harm Reduction Course

 

Treating Opioid Use Disorder in the ED

  • Identify the opioid epidemic
  • Recognize how to treat Opioid Use Disorder (OUD)
  • Overcome barriers to using medications for treatment of OUD (MOUD)
  • Assemble an interdisciplinary team to implement ED MOUD
  • Recognize resources and support from Rush and IDHS

Faculty Sophia Peng, MD

Credits offered:

AMA PRA Category 1 Credit(s)™-1.00

CNE - 1.00

CPE - 1.00

This course is coming soon!

 


In support of improving patient care, Rush University Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

These courses have been approved for AMA PRA Category 1 Credit(s)™.